In this GEN webinar, Jeremy Tomlinson, PhD, will discuss the pathogenesis of MASLD, share examples from recent research that ...

The disruption of abnormal activity in the gut microbiome may increase our risk for neurological disease, research suggests.

Results suggest novel roles for LINE1 transposable elements that can be explored in the contexts of diseases, from ...

Pfizer will apply Triana Biomedicines’ target-first and proximity-first discovery platform to discover molecular glue degraders for unspecified “multiple” targets in oncology and several other disease ...

Researchers used gene therapy to convert harmful fatty acids into beneficial ones to help combat childhood obesity.

Investors shrugged as Illumina pressed its case for building on its longtime leadership in next-generation sequencing, ...

The company reflects on their latest IND approval, the evolution of their end-to-end drug discovery platform, and what’s next ...

Researchers suggest findings could help to pinpoint cell types most vulnerable to conditions such as schizophrenia, and ...

Illumina unveiled its MiSeq i100 Series of sequencing systems: two new benchtop instruments, MiSeq i100 and MiSeq i100 Plus ...

Mark Munch, president of Bruker Nano Group, talks to GEN about Bruker’s reasons for acquiring Nanostring and their vision for ...

Findings implied more generally that the effects of dietary restriction on health and lifespan may be partially ...

Improving global diversity of global datasets will enable researchers to better serve underrepresented groups and advance our ...